Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP299655.RAACI_BO_aqnBvFiYicQ8-EY4eqvL5wj-f4LsrHap1XPU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP299655.RAACI_BO_aqnBvFiYicQ8-EY4eqvL5wj-f4LsrHap1XPU130_assertion type Assertion NP299655.RAACI_BO_aqnBvFiYicQ8-EY4eqvL5wj-f4LsrHap1XPU130_head.
- NP299655.RAACI_BO_aqnBvFiYicQ8-EY4eqvL5wj-f4LsrHap1XPU130_assertion wasGeneratedBy ECO_0000203 NP299655.RAACI_BO_aqnBvFiYicQ8-EY4eqvL5wj-f4LsrHap1XPU130_provenance.
- NP299655.RAACI_BO_aqnBvFiYicQ8-EY4eqvL5wj-f4LsrHap1XPU130_assertion wasDerivedFrom befree-20140225 NP299655.RAACI_BO_aqnBvFiYicQ8-EY4eqvL5wj-f4LsrHap1XPU130_provenance.
- NP299655.RAACI_BO_aqnBvFiYicQ8-EY4eqvL5wj-f4LsrHap1XPU130_assertion SIO_000772 21607557 NP299655.RAACI_BO_aqnBvFiYicQ8-EY4eqvL5wj-f4LsrHap1XPU130_provenance.
- NP299655.RAACI_BO_aqnBvFiYicQ8-EY4eqvL5wj-f4LsrHap1XPU130_assertion evidence source_evidence_literature NP299655.RAACI_BO_aqnBvFiYicQ8-EY4eqvL5wj-f4LsrHap1XPU130_provenance.
- NP299655.RAACI_BO_aqnBvFiYicQ8-EY4eqvL5wj-f4LsrHap1XPU130_assertion description "[Gemcitabine (GEM), a standard therapeutic drug for PC, was examined for the regulation of WT1 expression and the sensitizing effect on PC cells with WT1-specific antitumor immune response.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP299655.RAACI_BO_aqnBvFiYicQ8-EY4eqvL5wj-f4LsrHap1XPU130_provenance.